Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular diagnostics.

Rita M Braziel1, Margaret A Shipp, Andrew L Feldman

  • 1Oregon Health and Sciences University, Department of Pathology, Portland, OR 97239, USA.

Hematology. American Society of Hematology. Education Program
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No association of prior administration of selected vaccines with lymphoma prognosis.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

The American journal of surgical pathology·2026
Same author

Next-generation sequencing for lymphoid neoplasms: Real-world utility from a clinical assay.

Human pathology·2026
Same author

High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes.

American journal of hematology·2026
Same author

Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes.

British journal of haematology·2026
Same author

Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study.

Blood advances·2026

Molecular diagnostics are revolutionizing hematologic disease treatment by analyzing genetic, genomic, and proteomic profiles. These advancements offer personalized patient care and improved therapeutic strategies for hematologic disorders.

Area of Science:

  • Hematology
  • Molecular Diagnostics
  • Genomics
  • Proteomics

Background:

  • Molecular diagnostics are crucial for future safe and effective disease therapy.
  • Accumulating data on genetic, genomic, and proteomic profiles of hematopoietic diseases.
  • Understanding the molecular basis of hematologic disorders is key to patient care.

Purpose of the Study:

  • To review new technologies and advancements in molecular hematopathology.
  • To provide an overview of new information and its significance in patient care.
  • To highlight challenges in implementing new molecular information and techniques.

Main Methods:

  • Discussion of genetic information and research technologies in diagnostic molecular hematopathology.

Related Experiment Videos

  • Update on genomic profiling of malignant lymphomas, including gene expression profiling.
  • Presentation of proteomic analysis technologies for identifying proteins and networks in hematopoietic malignancies.

    • Main Results:

    • New genetic information impacts diagnostic molecular hematopathology practices.
    • Genomic profiling of malignant lymphomas reveals clinical and therapeutic applications.
    • Proteomic analysis offers potential therapeutic and prognostic value in hematologic malignancies.

    Conclusions:

    • Molecular diagnostics are pivotal for personalized therapy in hematologic disorders.
    • Advancements in genetic, genomic, and proteomic analyses enhance understanding and treatment.
    • Elucidation of molecular pathways holds significant promise for patient care in hematologic malignancies.